Fig. 2From: Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancerHigh expression of thymosin beta 10 (TMSB10) in breast cancer tissue samples correlates with advanced clinicopathological features and poor patient survival. a Representative images of TMSB10 expression in normal breast tissue and breast cancer tissue samples at different clinical stages. b Number of breast cancer tissue samples at stages I-II or III-IV in different staining index groups on immunohistochemical analysis (IHC). c and d Kaplan-Meier overall survival and distant metastasis-free survival curves for patients with breast cancer stratified by high and low expression of TMSB10. e and f Multivariate Cox regression analysis to evaluate the significance of the association between TMSB10 expression and overall survival and metastasis-free survival. Hazard ratios are presented by log2 transformation. PR progesterone receptor, ER estrogen receptor, T tumor, N nodes M metastasisBack to article page